BusinessAkari Therapeutics to Attend Upcoming Investor Conferences In NovemberBy Nasdaq OMXNov 11, 2016, 12:00 PM UTC
BusinessAkari Therapeutics to Present Abstract on Potential Once Weekly PAS-Coversin at the 58th Annual Meeting of the American Society of HematologyBy Nasdaq OMXNov 3, 2016, 12:01 PM UTC
BusinessAkari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With CoversinBy Nasdaq OMXMar 31, 2016, 8:03 PM UTC
BusinessAchillion Reports 2015 Fourth Quarter and Year-End Financial ResultsBy Nasdaq OMXFeb 25, 2016, 11:05 AM UTC
